Get startedLog in
    Picture of UroGen Pharma logo

    URGN — UroGen Pharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Urogen Pharma falls on CFO appointment

    Picture of UroGen Pharma logoUroGen Pharma
    09/10/2024 15:27
    ** Nasdaq- listed shares of UroGen Pharma  UR8.F  down about
8% at $12 in morning trade - hitting a nearly one- year low
    ** The Israeli biotech company appoints Chris Degnan as
Chief Financial Officer
    ** Chris Degnan succeeds Don Kim as CFO 
    ** Including session's losses, stock down about 18.8% YTD


 (Reporting by Sruthi Narasimha Chari in Bengaluru)
 ((Sruthinarasimha.chari@thomsonreuters.com))

    Recent news on UroGen Pharma

    See all news